CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
10.97
-0.30 (-2.66%)
Oct 9, 2025, 3:49 PM EDT - Market open
CorMedix Stock Forecast
Stock Price Forecast
The 7 analysts that cover CorMedix stock have a consensus rating of "Strong Buy" and an average price target of $17.57, which forecasts a 60.16% increase in the stock price over the next year. The lowest target is $12 and the highest is $22.
Price Target: $17.57 (+60.16%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 9, 2025.
Analyst Ratings
The average analyst rating for CorMedix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 3 | 3 | 3 | 4 | 4 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $22 | Buy | Reiterates | $22 | +100.55% | Sep 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $17 | Strong Buy | Maintains | $20 → $17 | +54.97% | Aug 8, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +82.32% | Jun 30, 2025 |
| Needham | Needham | Strong Buy Maintains $15 → $20 | Strong Buy | Maintains | $15 → $20 | +82.32% | Jun 24, 2025 |
Financial Forecast
Revenue This Year
252.36M
from 43.47M
Increased by 480.51%
Revenue Next Year
403.30M
from 252.36M
Increased by 59.81%
EPS This Year
1.62
from -0.30
EPS Next Year
2.35
from 1.62
Increased by 45.02%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 276.9M | 511.6M | |||
| Avg | 252.4M | 403.3M | |||
| Low | 201.7M | 297.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 536.9% | 102.7% | |||
| Avg | 480.5% | 59.8% | |||
| Low | 364.0% | 17.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.15 | 3.40 | |||
| Avg | 1.62 | 2.35 | |||
| Low | 1.30 | 1.69 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 110.1% | |||
| Avg | - | 45.0% | |||
| Low | - | 4.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.